On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

Q3 2024 Earnings Call Transcript October 15, 2024 Johnson & Johnson beats earnings expectations. Reported EPS is $2.42, ...

Good morning, and welcome to Johnson & Johnson's third-quarter 2024 earnings conference call. (Operator Instructions) This call is being recorded. If anyone has any objections, you may disconnect at ...

Here are eight key developments from spine and orthopedic devicemakers since Oct. 9. 1. Johnson & Johnson MedTech began the ...

Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), retaining the price ...

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

Johnson & Johnson (JNJ) stock is experiencing a positive trading ... marking a 5% year-over-year increase. However, the ...

The Liberia Petroleum Refining Corporation (LPRC), under its new Managing Director, Amos Tweh, has implemented key measures to revitalize Liberia’s oil and gas sector and alleviate the economic strain ...

He worked at Edwards Lifesciences for more than six years, culminating in a role in clinical operations. After Edwards, ...

Carlos Tavares, Chief Executive Officer of Stellantis, poses in front of a Citroen C5 Aircross concept car on media day at the 2024 Paris Auto Show in Paris, France, October 14, 2024. REUTERS ...